BackFirst Tracks Biotherapeutics Ordinary Shares When-Issued Overview

First Tracks Biotherapeutics Ordinary Shares When-Issued Total Current Liabilities

Track First Tracks Biotherapeutics Ordinary Shares When-Issued's total current liabilities ($18M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$18.09M

Peer trimmed avg / median

Loading

First Tracks Biotherapeutics Ordinary Shares When-Issued Total Current Liabilities History

Loading

First Tracks Biotherapeutics Ordinary Shares When-Issued vs. peers: Total Current Liabilities Comparison

Loading

First Tracks Biotherapeutics Ordinary Shares When-Issued Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

First Tracks Biotherapeutics Ordinary Shares When-Issued (TRAXV) FAQ

As of the most recent data (September 2026), TRAXV shows a total current liabilities of $18M. Scroll down for historical charts and peer comparison views.

Tracking TRAXV's total current liabilities over time shows whether First Tracks Biotherapeutics Ordinary Shares When-Issued is scaling, shrinking, or reshaping that part of the business. The current reading is $18M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has First Tracks Biotherapeutics Ordinary Shares When-Issued's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $18M) with ownership activity and broader fundamentals.

First Tracks Biotherapeutics Ordinary Shares When-Issued's total current liabilities is $18M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.